MENU
BOLD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Boundless Bio (BOLD) Earnings Date & Reports

Boundless Bio Inc is a clinical-stage oncology company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

BOLD is expected to report earnings to rise 55.71% to -109 cents per share on November 06

Boundless Bio BOLD Stock Earnings Reports
Q3'25
Est.
$-1.09
Q2'25
Beat
by $0.32
Q1'25
Beat
by $1.73
Q4'24
Beat
by $0.10
Q3'24
Missed
by $0.01
The last earnings report on August 05 showed earnings per share of -69 cents, beating the estimate of -101 cents. With 66.72K shares outstanding, the current market capitalization sits at 24.18M.
View a ticker or compare two or three
BOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. BOLD showed earnings on August 05, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of gene therapy products for patients with serious rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9880 Campus Point Drive
Phone
+1 858 766-9912
Employees
72
Web
https://www.boundlessbio.com